🔴 Helius Medical Technologies is trading 5.06% down in pre-market — no new company-specific catalyst identified

Helius Medical Technologies is trading 5.06% down at $1.69 in pre-market, with no new company-specific announcement identified for August 19, 2026.

• The latest confirmed catalyst was the August 14 earnings release, which reported $2.5 million in quarterly revenue alongside a net loss.
• The release also detailed a strategic shift toward Solana infrastructure, but the news is several sessions old and does not clearly explain this pre-market decline.